Industry News

The Future of Independent Pharmacy: A Personal Perspective

The future of independent pharmacy is bright, but it requires adaptation and a focus on clinical excellence and community engagement. ...

FDA Crackdown Ends the Shortage Loophole: What the New GLP-1 Compounding Rules Mean for Pharmacies

The FDA has closed the shortage loophole that fueled the compounded GLP-1 boom. With semaglutide and tirzepatide off the shortage list, compounding pharmacies and telehealth platforms face a new era of enforcement, audits, and market consolidation.
spot_imgspot_img

Digital Couponing

A New Superpower for Independent Retail Pharmacies By: Karen Deckard, Director of Sales & Marketing at Retail Management Solutions More than...

What 150 Years Could Not Kill

A Pharmacy Story. A Profession’s Warning. A Call to Act. In 1876, a young pharmacist named J.E. Janney apprenticed under...

Made to Order: How Personalization Became Pharmacy’s Best Business Model

The Full Circle The first pharmacies were compounding labs. Pharmacists stood behind wooden counters mixing remedies tailored to individual patients…...

Why Every Pharmacy Should Be Prescribing Birth Control

Author: Sally Rafie, PharmD, BCPS, APh, FCCP, FCPhA Community pharmacies are cornerstones of accessible healthcare, often seeing patients more frequently...

The GLP-1 Showdown: TrumpRx, Compounding Crackdowns, and the New Era of Drug Pricing

The pharmaceutical landscape is currently witnessing a tectonic shift as federal policy, aggressive private-sector innovation, and regulatory enforcement collide....

The Appeal Advantage: Turning PBM Reform Laws Into Recovered Revenue

The Shiny Toy Problem New PBM reform laws make headlines. Pharmacy owners celebrate. State associations post press releases. Everyone feels...